Home > Journals > Minerva Ginecologica > Past Issues > Articles online first > Minerva Ginecologica 2020 Oct 01

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Publication history
Reprints
Permissions
Cite this article as

 

 

Minerva Ginecologica 2020 Oct 01

DOI: 10.23736/S0026-4784.20.04675-4

Copyright © 2020 EDIZIONI MINERVA MEDICA

language: English

An innovative device in the management of female urodynamic stress incontinence: a perception survey

Marco SOLIGO 1 , Marco TORELLA 2, Matteo BALZARRO 3, Maria Grazia MATARAZZO 4, Andrea BRAGA 5, Maurizio SERATI 6, on behalf of the Italian Urodynamic Society (SIUD)

1 Urogynecology Unit, Department of Woman, Mother, and Neonate, Buzzi Children's Hospital, ASST Fatebenefratelli‐Sacco, University of Milan, Milan, Italy; 2 Department of Gynaecology, Obstetric and Reproductive Science, Second University of Studies of Naples, Naples, Italy; 3 Department of Urology Azienda Ospedaliera Universitaria Integrata Verona, Verona, Italy; 4 Gynecological Clinic, Policlinico Universitario-Catania, Catania, Italy; 5 Department of Obstetrics and Gynecology, EOC - Beata Vergine Hospital, Mendrisio, Switzerland; 6 Department of Obstetrics and Gynecology, University of Insubria, Varese, Italy



Urinary Incontinence significantly affects daily life of suffering women. Minimally invasive solutions to cope with urine leakage would be of great interest. A Survey to investigate efficacy and compliance of an innovative intravaginal device (Diveen®) to reduce the risk of urine leakage was performed in 5 Urogynecological Centers across Italy. Women with Urodynamic diagnosis of Stress Incontinence, included Mixed conditions, underwent the survey. The device was effective (60%) independently from severity of Incontinence or the presence of concomitant detrusor overactivity (Mixed forms) with a positive impact on Quality of Life in more than half of the women. Also compliance with the device was satisfactory (up to 73%) Clinically symptomatic prolapse and age >65 years are the only limiting factors in terms of efficacy and compliance, while the menopausal status would not seem to affect these aspects. Despite global satisfactory outcomes 46% of the surveyed women declare their propensity to use the device. This data deserves further investigation.


KEY WORDS: Survey; Urinary incontinence, leakage; Urodynamics; Quality of Life, compliance, efficacy, device

top of page